Citigroup’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed -$27 4761
2024
Q4
$27 Sell
2
-6
-75% -$81 ﹤0.01% 4869
2024
Q3
$65 Sell
8
-3,164
-100% -$25.7K ﹤0.01% 4720
2024
Q2
$27K Buy
3,172
+2,425
+325% +$20.6K ﹤0.01% 4169
2024
Q1
$13K Buy
747
+187
+33% +$3.25K ﹤0.01% 4383
2023
Q4
$7.19K Sell
560
-17,564
-97% -$225K ﹤0.01% 4504
2023
Q3
$671K Sell
18,124
-1,146
-6% -$42.4K ﹤0.01% 2198
2023
Q2
$776K Sell
19,270
-17,179
-47% -$691K ﹤0.01% 2424
2023
Q1
$2.64M Sell
36,449
-4,568
-11% -$331K ﹤0.01% 1387
2022
Q4
$3.36M Sell
41,017
-10,568
-20% -$867K ﹤0.01% 1243
2022
Q3
$4.88M Buy
51,585
+10,243
+25% +$968K ﹤0.01% 1148
2022
Q2
$8.05M Buy
41,342
+6,736
+19% +$1.31M 0.01% 912
2022
Q1
$8.04M Sell
34,606
-5,925
-15% -$1.38M ﹤0.01% 987
2021
Q4
$16M Buy
40,531
+29,697
+274% +$11.7M 0.01% 754
2021
Q3
$4.85M Sell
10,834
-6,340
-37% -$2.84M ﹤0.01% 1327
2021
Q2
$6.68M Buy
17,174
+45
+0.3% +$17.5K ﹤0.01% 1248
2021
Q1
$6.15M Sell
17,129
-33,422
-66% -$12M ﹤0.01% 1229
2020
Q4
$24.8M Buy
50,551
+43,536
+621% +$21.4M 0.01% 583
2020
Q3
$2.27M Sell
7,015
-1,984
-22% -$643K ﹤0.01% 1455
2020
Q2
$3.28M Buy
8,999
+393
+5% +$143K ﹤0.01% 1301
2020
Q1
$1.83M Buy
8,606
+1,325
+18% +$282K ﹤0.01% 1433
2019
Q4
$3M Buy
7,281
+1,224
+20% +$504K ﹤0.01% 1414
2019
Q3
$2.14M Buy
6,057
+3,285
+119% +$1.16M ﹤0.01% 1573
2019
Q2
$1.39M Buy
2,772
+2,166
+357% +$1.09M ﹤0.01% 1892
2019
Q1
$602K Sell
606
-3,884
-87% -$3.86M ﹤0.01% 2355
2018
Q4
$3.9M Buy
4,490
+1,147
+34% +$996K ﹤0.01% 1146
2018
Q3
$3.46M Buy
3,343
+1,118
+50% +$1.16M ﹤0.01% 1193
2018
Q2
$2.04M Sell
2,225
-158
-7% -$145K ﹤0.01% 1465
2018
Q1
$2.32M Buy
2,383
+2,374
+26,378% +$2.31M ﹤0.01% 1377
2017
Q4
$4K Buy
9
+6
+200% +$2.67K ﹤0.01% 4692
2017
Q3
$1K Sell
3
-4
-57% -$1.33K ﹤0.01% 4568
2017
Q2
$2K Sell
7
-3
-30% -$857 ﹤0.01% 4519
2017
Q1
$5K Sell
10
-1,756
-99% -$878K ﹤0.01% 4450
2016
Q4
$627K Buy
1,766
+1,678
+1,907% +$596K ﹤0.01% 2725
2016
Q3
$47K Sell
88
-152
-63% -$81.2K ﹤0.01% 3756
2016
Q2
$135K Sell
240
-239
-50% -$134K ﹤0.01% 3120
2016
Q1
$228K Buy
479
+415
+648% +$198K ﹤0.01% 3372
2015
Q4
$42K Sell
64
-567
-90% -$372K ﹤0.01% 4169
2015
Q3
$496K Buy
631
+620
+5,636% +$487K ﹤0.01% 2214
2015
Q2
$14K Sell
11
-1,035
-99% -$1.32M ﹤0.01% 4428
2015
Q1
$1.09M Buy
1,046
+1,007
+2,582% +$1.05M ﹤0.01% 1696
2014
Q4
$26K Buy
+39
New +$26K ﹤0.01% 4465